Dasatinib Medications
Dasatinib (Sprycel) is a medication classified as a tyrosine kinase inhibitor. It is primarily used to address specific blood cancers, blocking signals that cause the uncontrolled growth of leukaemia cells. This page provides information regarding the currently listed film-coated tablet formulation available for patients in Thailand and the Philippines.
Medicine containing Dasatinib
What is Dasatinib?
Dasatinib is a targeted therapy that belongs to the kinase inhibitor class of pharmaceutical agents. It is designed to interrupt the signals that allow specific cancer cells to multiply. By focusing on these pathways, the medication addresses the underlying causes of certain blood-cell disorders.
What Dasatinib is used for
Medical professionals use this medication to address Chronic Myeloid Leukaemia in patients who are intolerant or resistant to prior treatments. It is also utilised for Acute Lymphoblastic Leukaemia when specific genetic markers are present. The selection of this therapeutic option depends on the type of leukaemia and individual genetic profiles.
How does Dasatinib work?
The medication works by inhibiting several tyrosine kinases, which are enzymes that act as molecular switches for cell growth. In cancer cells, these switches become stuck in the active position, leading to uncontrolled proliferation. By blocking these enzymes, the treatment causes the malignant cells to stop dividing.
Dasatinib brands and forms
The medication is typically available as a film-coated tablet. While Sprycel acts as the originator brand for this compound, manufacturing standards ensure that different versions function in a similar manner. Access to these treatments is part of broader Oncology Support measures. Patients often discuss the appropriate formulation with their medical team based on their specific administration needs.
Finding Dasatinib in Thailand and the Philippines
Detailed information regarding available brands can be found for patients across Thailand and the Philippines. The inclusion of generic alternatives has widened access to this therapy. This availability also extends to patients in other Asian markets including Indonesia, Hong Kong and Taiwan. All treatment plans should be arranged in collaboration with a qualified oncologist.
Safety overview for Dasatinib
What to check before using this medicine
Review your medical history, specifically regarding cardiac or pulmonary conditions. Confirm the status of your liver and kidney function with a clinical professional.
Possible reactions and tolerability
Common responses may include fatigue, fluid retention, or changes in blood cell counts. Monitor for any signs of respiratory distress or unexpected bleeding.
Interactions and health factors
This agent can interact with various gastric acid reducers and certain systemic medications. Awareness of concurrent supplements and medications is necessary to identify potential drug-drug interactions. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.
Important safety information for Dasatinib
This article serves as an educational overview and does not constitute medical advice or a recommendation for use. Products differ in formulation, strength and directions. This page does not authorise clinical application or unsupervised use of any pharmaceutical agent. You must review the individual product labelling and speak with a healthcare professional regarding your specific condition when clinical judgement is needed.